CASI insider filings

CASI Pharmaceuticals, Inc. — 25 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2022-09-09. Screen CASI transaction legs live →

Insider transaction summary — last 90 days

No insider filings (Forms 3/4/5) for CASI between 2026-08-23 and 2026-11-21. The table below lists the most recent filings on record.

Recent insider filings — CASI Pharmaceuticals, Inc.

FiledFormInsiderReported transactionsSource
2022-09-094Zukiwski Alexander A — EVP and Chief Medical OfficerGrant/award (A): 3,000 (derivative) @ $0EDGAR
2022-09-084Huang James — DirectorPurchase (P): 19,162 @ $3.89 · Purchase (P): 3,111 @ $4.00 · Purchase (P): 33,300 @ $4.28EDGAR
2022-09-024Huang James — DirectorPurchase (P): 24,975 @ $3.75 · Purchase (P): 11,821 @ $3.72 · Purchase (P): 400 @ $3.74EDGAR
2022-08-264Huang James — DirectorPurchase (P): 5,000 @ $3.75 · Purchase (P): 39,527 @ $3.75EDGAR
2022-08-234Huang James — DirectorPurchase (P): 171,116 @ $3.27 · Purchase (P): 23,105 @ $3.46 · Purchase (P): 40,000 @ $3.50EDGAR
2022-06-174He Wei-Wu — Chairman and CEO, Director, 10% ownerPurchase (P): 36,058 @ $2.97 · Purchase (P): 2,096 @ $3.06 · Purchase (P): 50,000 @ $3.18EDGAR
2022-05-264Wu Yue Alexander — DirectorGrant/award (A): 388,387 (derivative) @ $0EDGAR
2022-05-264Salisbury Franklin Cary jr — DirectorGrant/award (A): 388,387 (derivative) @ $0EDGAR
2022-05-264Huang James — DirectorGrant/award (A): 397,419 (derivative) @ $0EDGAR
2022-05-264Zhou Quan — DirectorGrant/award (A): 380,645 (derivative) @ $0EDGAR
2022-05-264SHROTRIYA RAJESH C MD — DirectorGrant/award (A): 345,806 (derivative) @ $0EDGAR
2021-12-064Zukiwski Alexander A — Chief Medical OfficerGrant/award (A): 500,000 (derivative) @ $0EDGAR
2021-11-194He Wei-Wu — Chairman and CEO, DirectorPurchase (P): 200,000 @ $0.99 · Purchase (P): 200,000 @ $0.98EDGAR
2021-08-204He Wei-Wu — Chairman and CEO, DirectorPurchase (P): 300,000 @ $1.29 · Purchase (P): 180,000 @ $1.26EDGAR
2021-07-264Zhang Larry — PresidentGrant/award (A): 800,000 (derivative) @ $0EDGAR
2021-06-164Wu Yue Alexander — DirectorGrant/award (A): 110,459 (derivative) @ $0EDGAR
2021-06-164Salisbury Franklin Cary jr — DirectorGrant/award (A): 110,459 (derivative) @ $0EDGAR
2021-06-164Huang James — DirectorGrant/award (A): 113,028 (derivative) @ $0EDGAR
2021-06-164He Wei-Wu — Chairman and CEO, Director, 10% ownerGrant/award (A): 4,000,000 (derivative) @ $0EDGAR
2021-06-164Zhou Quan — DirectorGrant/award (A): 108,257 (derivative) @ $0EDGAR
2021-06-164SHROTRIYA RAJESH C MD — DirectorGrant/award (A): 98.35 (derivative) @ $0EDGAR
2021-03-304He Wei-Wu — Chairman and CEO, DirectorPurchase (P): 3,000,000 @ $2.05EDGAR
2020-12-234He Wei-Wu — Chairman and CEO, DirectorGift (G): 380,000 @ $0EDGAR
2020-12-184Xu Weihao — Chief Financial OfficerPurchase (P): 2,000 @ $2.44 · Purchase (P): 1,721 @ $2.64 · Purchase (P): 2,279 @ $2.63 · Grant/award (A): 800,000 (derivative) @ $0EDGAR
2020-11-244He Wei-Wu — Chairman and CEO, DirectorPurchase (P): 127,471 @ $2.12 · Purchase (P): 100,000 @ $2.18EDGAR

Recent 8-K events — CASI Pharmaceuticals, Inc.

Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →

FiledFormItems reportedSource
2023-03-218-K5.07 — Submission of Matters to a Vote of Security Holders
8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2023-01-318-K1.01 — Entry into a Material Definitive Agreement
9.01 — Financial Statements and Exhibits
EDGAR
2022-11-148-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2022-09-238-K1.01 — Entry into a Material Definitive Agreement
9.01 — Financial Statements and Exhibits
EDGAR
2022-08-128-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2022-05-268-K3.03 — Material Modification to Rights of Security Holders
5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2022-05-258-K5.07 — Submission of Matters to a Vote of Security HoldersEDGAR
2022-05-258-K8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2022-05-248-K1.01 — Entry into a Material Definitive Agreement
9.01 — Financial Statements and Exhibits
EDGAR
2022-05-248-K1.01 — Entry into a Material Definitive Agreement
2.03 — Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
9.01 — Financial Statements and Exhibits
EDGAR
Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?ticker=CASI returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs